Sara Meltzer

Sara Meltzer


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 2010 in BJOG: An International Journal of Obstetrics & Gynaecology
Verified
Journal Article
Closed access
PDF file
SMSara Meltzer
Sara Meltzer
JSJ Snyder
J Snyder
JPJr Penrod
Jr Penrod
MNM Nudi
M Nudi
LML Morin
L Morin

Joseph MussaJoseph Mussa
Joseph Mussa
SMSara Meltzer
Sara Meltzer
RBRachel Bond
Rachel Bond
NGNatasha Garfield
Natasha Garfield
KDKaberi Dasgupta
Kaberi Dasgupta
Canada’s largest national obstetric and diabetology organizations have recommended various algorithms for the screening of gestational diabetes mellitus (GDM) over the years. Though uniformity across recommendations from clinical practice guidelines (CPGs) is desirable, historically, national guidelines from Diabetes Canada (DC) and the Society of Obstetricians and Gynaecologists of Canada (SOGC) have differed. Lack of consensus has led to variation in screening approaches, rendering precise ascertainment of GDM prevalence challenging. To highlight the reason and level of disparity in Canada, we conducted a scoping review of CPGs released by DC and the SOGC over the last thirty years and distributed a survey on screening practices among Canadian physicians. Earlier CPGs were based on expert opinion, leading to different recommendations from these organizations. However, as a result of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study, disparities between DC and the SOGC no longer exist and many Canadian physicians have adopted their recent recommendations. Given that Canadian guidelines now recommend two different screening programs (one step vs. two step), lack of consensus on a single diagnostic threshold continues to exist, resulting in differing estimates of GDM prevalence. Our scoping review highlights these disparities and provides a step forward towards reaching a consensus on one unified threshold.

30 June 2014 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
ABAnne-Sophie Brazeau
Anne-Sophie Brazeau
ALAaron Leong
Aaron Leong
SMSara Meltzer
Sara Meltzer
RCRani Cruz
Rani Cruz
DDDeborah DaCosta
Deborah DaCosta
MGMoMM study group
MoMM study group
Women with gestational diabetes history are at increased risk for type 2 diabetes. They face specific challenges for behavioural changes, including childcare responsibilities. The aim of this study is to test a tailored type 2 diabetes prevention intervention in women within 5 years of a pregnancy with gestational diabetes, in terms of effects on weight and cardiometabolic risk factors.

2 May 2018 in BMC Public Health
Verified
Journal Article
Open access
PDF file
ABAnne-Sophie Brazeau
Anne-Sophie Brazeau
SMSara Meltzer
Sara Meltzer
RPRomina Pace
Romina Pace
NGNatasha Garfield
Natasha Garfield
AGAriane Godbout
Ariane Godbout
KDKaberi Dasgupta
Kaberi Dasgupta
We recently demonstrated that a gestational diabetes history in mothers is associated with higher postpartum incident diabetes not only in mothers but also in fathers. In the present study, we examined changes in health behaviours and cardiometabolic profiles in both mothers and partners who participated in a diabetes prevention program within 5 years of a gestational diabetes pregnancy. Couples were enrolled into a 13-week program that included 5 half-day group sessions and web/telephone-based support between sessions. It was designed in consultation with patients and previously studied in mothers. We computed mean changes from baseline (95% CI) for physical activity, eating, and sleep measures, and cardiometabolic parameters (fasting and 2-h post glucose load plasma glucose, BMI, blood pressure) in both partners and mothers. Among 59 couples enrolled, 45 partners (76%) and 47 mothers (80%) completed final evaluations. Baseline cardiometabolic measures averaged within normal limits. Similar to mothers, partners increased physical activity (+ 1645 steps/day, 95%CI 730, 2561; accelerometer assessed moderate-to-vigorous physical activity + 36.4 min/week, 95% CI 1.4, 71.4) and sleep duration (+ 0.5 h/night, 95% CI 0.1, 0.9) and reduced the sodium-to-potassium ratio of food intake (− 0.09 95% CI -0.19, − 0.001). No conclusive changes were observed in glucose measures or insulin resistance; in analyses combining mothers and partners, systolic blood pressure decreased (− 2.7 mmHg, 95% CI -4.4, − 1.0). Partners and mothers demonstrated improved physical activity, sleep, and dietary quality. Baseline cardiometabolic profiles averaged at normal values and there were no changes in glucose or insulin resistance; some blood pressure impact was observed. While strategies need to be developed to attract participants at higher cardiometabolic risk, this study demonstrates that partners of women within 5 years of a gestational diabetes diagnosis can be recruited and do achieve health behaviour change. ClinicalTrials.gov: NCT02343354 (date of registration: January 22, 2015).

1 December 2010 in Diabetes Care
Verified
Journal Article
Open access
SMSara Meltzer
Sara Meltzer

30 September 2014 in BMJ
Verified
Journal Article
Closed access
PDF file
SMSara Meltzer
Sara Meltzer
Another good reason for young women to quit smoking, eat better, and exercise